The pandemic that is shaping us

Our experts

I chose to focus my work on vaccines and infectious diseases because it’s been a long-standing passion of mine. I hold a PhD in immunology, and so supporting clients who focus on innovation in this space is something that I’ve dedicated a large portion of my life to.

Partner, Chicago
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Video

      Achieving the impossible in vaccine innovation

      Getting to work: Employers’ role in COVID-19 vaccination
      Article
      Getting to work: Employers’ role in COVID-19 vaccination
      -
      A light at the end of the tunnel: US COVID-19 vaccine administration
      Article
      A light at the end of the tunnel: US COVID-19 vaccine administration
      -
      Guarav Agrawal

      I’ve always been passionate about the intersection of science, business, and patients. For more than a decade, I’ve focused on how clients can bring scientific breakthroughs more efficiently to patients.

      Partner, New York
      Video Player is loading.
      Current Time 0:00
      Duration 0:00
      Loaded: 0%
      Stream Type LIVE
      Remaining Time 0:00
       
      1x
        • Chapters
        • descriptions off, selected
        • captions off, selected
          Video

          Working across the COVID-19 ecosystem

          Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?
          Article
          Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?
          -
          Biopharma 2020: A landmark year and a reset for the future
          Article
          Biopharma 2020: A landmark year and a reset for the future
          -
          Tania Holt

          I’m really proud of being part of making sure that the vaccines reach everybody in the world and not just the high-income countries. It requires global collaboration and there is more to do in making this a reality.

          Partner, London
          Video Player is loading.
          Current Time 0:00
          Duration 0:00
          Loaded: 0%
          Stream Type LIVE
          Remaining Time 0:00
           
          1x
            • Chapters
            • descriptions off, selected
            • captions off, selected
              Video

              Seeking global solutions for a global pandemic

              Africa needs vaccines. What would it take to make them here?
              Article
              Africa needs vaccines. What would it take to make them here?
              -
              The COVID-19  vaccines are here: What comes next?
              Article
              The COVID-19 vaccines are here: What comes next?
              -

              I think we’ll reflect back 20 years from now and say this was a warning sign of something bigger that can come, and there’s going to be a real catalyst that comes out of COVID-19.

              Senior Partner, Chicago
              Video Player is loading.
              Current Time 0:00
              Duration 0:00
              Loaded: 0%
              Stream Type LIVE
              Remaining Time 0:00
               
              1x
                • Chapters
                • descriptions off, selected
                • captions off, selected
                  Video

                  Catalyzing and changing our preparedness for the future

                  When will the COVID-19 pandemic end?
                  Article
                  When will the COVID-19 pandemic end?
                  -
                  On pins and needles: Will COVID-19 vaccines ‘save the world’?
                  Article
                  On pins and needles: Tracking COVID-19 vaccines and therapeutics
                  -
                  Michael Conway

                  I care about meeting people’s unmet needs. In developed countries, I've spent time working on vaccines that prevent illnesses that cause mortality in old people and in developing countries, addressing diseases affecting children.

                  Senior Partner, Philadelphia
                  Video Player is loading.
                  Current Time 0:00
                  Duration 0:00
                  Loaded: 0%
                  Stream Type LIVE
                  Remaining Time 0:00
                   
                  1x
                    • Chapters
                    • descriptions off, selected
                    • captions off, selected
                      Video

                      Changing the infectious disease landscape through vaccines

                      COVID-19 vaccines meet 100 million uncertain Americans
                      Article
                      COVID-19 vaccines meet 100 million uncertain Americans
                      -
                      Refueling the innovation engine in vaccines
                      Article
                      Refueling the innovation engine in vaccines
                      -

                      There are many aspects of the science, and of the public health and epidemiology literature, to consider, which we bring as a fact base to support meaningful decisions our clients make that impact people’s lives every single day.

                      Partner, Philadelphia
                      Video Player is loading.
                      Current Time 0:00
                      Duration 0:00
                      Loaded: 0%
                      Stream Type LIVE
                      Remaining Time 0:00
                       
                      1x
                        • Chapters
                        • descriptions off, selected
                        • captions off, selected
                          Video

                          Considering every aspect of society

                          Getting shots into arms: How US states are addressing the vaccine distribution challenge
                          Article
                          “Getting shots into arms”: How US states are addressing the vaccine distribution challenge
                          -
                          Rebuilding clinician mental health after COVID-19
                          Article
                          Rebuilding clinician mental health and well-being after COVID-19
                          -
                          Lieven Van der Veken

                          The biggest risk I see is inequity. Of course, we have certain populations and certain environments running ahead, as fast as they can, but in the end, nobody’s safe until everybody’s safe from the pandemic.

                          Senior Partner, Geneva
                          Video Player is loading.
                          Current Time 0:00
                          Duration 0:00
                          Loaded: 0%
                          Stream Type LIVE
                          Remaining Time 0:00
                           
                          1x
                            • Chapters
                            • descriptions off, selected
                            • captions off, selected
                              Video

                              Setting ambitious goals to address vaccine access

                              The COVID-19 vaccine: Lessons and challenges
                              Podcast
                              The COVID-19 vaccine: Lessons and challenges
                              -
                              Not the last pandemic: Investing now to reimagine public-health systems
                              Article
                              Not the last pandemic: Investing now to reimagine public-health systems
                              -

                              Related

                              Healthcare Systems & Services
                              How We Help Clients
                              Public & Social Sector
                              Pharmaceuticals and Medical Products